A new case report in Medical Research Archives describes vaccine-derived spike mRNA in exosomes after 1,284 days, spike protein in plasma after 1,173 days, and plasmid-DNA elements in skin tissue after 1,364 days in a 55-year-old man after three Pfizer-BioNTech doses. It proves no frequency. But it refutes the absolute claim that these components are biologically relevant only for a short time.
Ugur Sahin described dendritic cells as the stated target of mRNA-LNP technology. A Nature Biotechnology paper from April 2026 shows: immune response does not depend on these cells. The lead author calls it, verbatim, unexpected.
In 2022, Bill Gates sits in the ABC studio of The View — promoting his book “How to Prevent the Next Pandemic”, published 3 May 2022 by Knopf Doubleday — and delivers a line that comes out with an unmistakable smirk pulling at the corner of his mouth:
A pattern consists of repetitions. This one is documented.
The Timeline # November 2020 — ZDF heute journal # Uğur Şahin in an interview on the BioNTech vaccine: the mRNA candidate was safe, 50 million doses would be delivered before the end of 2020. The decisive trial data were imminent. 1
On 5 May 2026, BioNTech announces: up to 1,860 jobs cut — 22 percent of its workforce. The plants in Idar-Oberstein and Marburg close by end of 2027. The CureVac sites too. COVID vaccine production transfers entirely to Pfizer.
The vaccination rate among over-60s for the flu shot is, according to the RKI, at its lowest level in 17 years [1]. The COVID-19 vaccination rate in this age group has fallen by more than a third compared to the previous season [2]. At the same time, data from Denmark show that different BioNTech batches showed different adverse-event rates — a study that the PEI dismissed as “not meaningful” without presenting its own data [3].
On 24 October 2021, Stefan Oelrich stood on the stage of the World Health Summit in Berlin. Bayer AG board member, head of the pharmaceutical division. Right in front of him: Federal Health Minister Jens Spahn. WHO Director-General Tedros Adhanom Ghebreyesus. EU Commission President Ursula von der Leyen [1].
On March 24, 2026, Donald Trump posted that he was pausing strikes on Iranian power plants. Minutes before: $580 million in oil futures, opposite bets on stock futures — simultaneously, with no public trigger.
Nikola Brindley had been a dental nurse for over a decade. She knew vaccines. When she was asked to take AstraZeneca’s COVID jab in July 2021, she agreed without hesitation. Within hours, she was in A&E. Multiple organ systems began to fail. “I collapsed on the doorway and pretty much lost the ability to walk,” she recalls. Today, she uses a wheelchair.
The Danish data shows what should never have happened: Identical product, completely different outcomes. Some batches cause illness. Some do — nothing at all. # In December 2025, Hamburg mathematics professor Hans-Juergen Bandelt published the first part of a three-part analysis on tkp.at. His starting point: the Danish study by Schmeling and Manniche, peer-reviewed and published in the European Journal of Clinical Investigation in 2023 [1]. His finding: More than 30% of BioNTech batches were practically ineffective — and the PEI knew it [2][3][4].
No monitoring, no data, no consequences — but the vaccines were of course “safe and effective.”
It is one of the biggest scandals in Germany’s postwar history — and hardly anyone is talking about it. BioNTech, the Mainz-based company celebrated as the hero of the pandemic, positioned itself legally so that it is formally not even a vaccine manufacturer. And the authority responsible for monitoring vaccine safety — the Paul Ehrlich Institute (PEI) — failed to evaluate the legally mandated data for years.
